Vor Biopharma's GAAP loss for 9M 2021 was $50.647 million, up 83% from $27.674 million in the previous year.
Vor Biopharma's GAAP loss for 9M 2021 was $50.647 million, up 83% from $27.674 million in the previous year.
Financial results
Vor Biopharma's GAAP loss for 9M 2021 was $50.647 million, up 83% from $27.674 million in the previous year. Source: 
ir.vorbio.com
ir.vorbio.com
English (US) 